(Q67525973)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1363051%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1363051%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

author name string

A. Svensson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1363051

18 September 2022

A. Carlsson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1363051

18 September 2022

M. L. Carlsson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1363051

18 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1363051

18 September 2022

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1363051%20AND%20SRC:MED&resulttype=core&format=json

Journal of neural transmission. General section

14 September 2019

published in

90

3

199–217

1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1363051

18 September 2022

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1363051%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1363051%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

199-217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1363051%20AND%20SRC:MED&resulttype=core&format=json

A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice

14 September 2019

cites work

1 reference

12 December 2020

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

12 December 2020

Concentration-dependent actions of stimulated dopamine release on neuronal activity in rat striatum

1 reference

12 December 2020

Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons

1 reference

12 December 2020

Motor depression: a new role for D1 receptors?

1 reference

12 December 2020

Striatal inhomogeneities and basal ganglia function

1 reference

12 December 2020

Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice

1 reference

12 December 2020

SCH 23390—The first selective dopamine D-1 antagonist

1 reference

12 December 2020

Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of γ-aminobutyric acid, glutamate or serotonin

1 reference

12 December 2020

The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys

1 reference

12 December 2020

Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain

1 reference

12 December 2020

Discharge patterns of pallidal neurons with input from various cortical areas during movement in the monkey.

1 reference

12 December 2020

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

1 reference

12 December 2020

MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease

1 reference

12 December 2020

SCH 23390--a selective dopamine D-1 receptor antagonist with putative 5-HT1 receptor agonistic activity

1 reference

12 December 2020

Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801

1 reference

12 December 2020

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

12 December 2020

Terminal excitability of the corticostriatal pathway. I. Regulation by dopamine receptor stimulation.

1 reference

12 December 2020

Interaction between glutamatergic and dopaminergic tone in the nucleus accumbens of mice: evidence for a dual glutamatergic function with respect to psychomotor control

1 reference

12 December 2020

Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism

1 reference

12 December 2020

Multiple sites for the regulation of the N-methyl-D-aspartate receptor

1 reference

12 December 2020

Genetic differences in the effects of competitive and non-competitive NMDA receptor antagonists on locomotor activity in mice

1 reference

12 December 2020

The effects of cortical ablation on multiple unit activity in the striatum following dexamphetamine

1 reference

12 December 2020

Dopamine agonists potentiate antiakinetic effects of competitive NMDA-antagonists in monoamine-depleted mice

1 reference

12 December 2020

Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle

1 reference

12 December 2020

D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

1 reference

12 December 2020

The behavioral pharmacology of NMDA receptor antagonists

1 reference

12 December 2020

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

1 reference

12 December 2020

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

1 reference

12 December 2020

Dopamine neurons of the monkey midbrain: contingencies of responses to stimuli eliciting immediate behavioral reactions

1 reference

12 December 2020

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

1 reference

12 December 2020

Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine

1 reference

12 December 2020

Effect of L-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies

1 reference

12 December 2020

Striatal dopamine and glutamate release: effects of intranigral injections of substance P

1 reference

12 December 2020

The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens

1 reference

12 December 2020

The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function

1 reference

12 December 2020

Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice

1 reference

12 December 2020

The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice

1 reference

12 December 2020

Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons.

1 reference

12 December 2020

Do endogenous excitatory amino acids influence striatal dopamine release?

1 reference

12 December 2020

Disinhibition as a basic process in the expression of striatal functions

1 reference

12 December 2020

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

12 December 2020

The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors

1 reference

12 December 2020

CY 208–243 behaves as a typical D-1 agonist in the reserpine-treated mouse

1 reference

12 December 2020

Terminal excitability of the corticostriatal pathway. II. Regulation by glutamate receptor stimulation

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01250961

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1363051%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference